The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 4,427 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 758 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
AMERISOURCEBERGEN CORP | COM | 03073E105 | 1,700 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
ANTARES PHARMA INC | COM | 036642106 | 1,410 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
CARDINAL HEALTH INC | COM | 14149Y108 | 1,770 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 1,564 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 1,043 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
CVS HEALTH CORP | COM | 126650100 | 3,715 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 167 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 1,166 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 4,549 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 4,699 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
GREENLANE HLDGS INC | CL A | 395330103 | 570 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 1,383 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
TYME TECHNOLOGIES INC | COM | 90238J103 | 3,045 | 2,175,000 | SH | SOLE | 2,175,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 2,005 | 250,000 | SH | SOLE | 250,000 | 0 | 0 |